Scientific board

The Scientific Board is composed of recognized experts who support research on medical cannabis.

Acting in a neutral and independent manner, they explore new therapeutic indications based on information directly  collected from patients and the medical profession.

In addition to providing objective scientific information to the public, they share the results of their research with the Swiss regulatory authorities in order to positively influence the legal framework.

claude vaney cannabis médical.jpeg
Screen Shot 2021-08-26 at 15.41.01.png

Dr. Claude Vaney, Chief of Neurorehabilitation Specialist in Neurology FMH.
President of the Swiss Society of Cannabis in Medicine.

Over the past few years, Claude Vaney has developed neurorehabilitation at the Bernese Montana Clinic and has developed it as a whole, particularly in the field of patients with multiple sclerosis and after a stroke.
Since then, he has dedicated himself to the medicalization of cannabis in his work as a practitioner at the Meyriez Hospital, as vice-president of the Swiss Multiple Sclerosis Society and as a member of the Parkinson.ch committee.
Since then, he dedicates his activity as a practitioner at the Meyriez hospital, as vice-president of the Swiss Multiple Sclerosis Society and within the committee of Parkinson.ch to the medicalization of cannabis.

davide staedler.jpeg
Screen Shot 2021-08-26 at 15.41.01.png

Davide Staedler, Dr ès sc. EPF; 

Privat Docent, Dip. di Scienze Biomediche, UNIL

Graduated from the University of Lausanne (Faculty of Biology and Medicine, 2010) with in medical biology and pharmacology, he holds a PhD in medicinal chemistry from the EPFL (2014).
Davide Staedler follows both an academic and a private sector career path. Since 2009 he has been managing the company TIBIO, specialized in scientific consulting in chemistry and biotechnology, which he founded during his studies in biology.
In parallel, from 2015 to 2021 he was Scientific Director of Scitec Research, one of the most important laboratories in Switzerland. Passionate about industrial applications, he is a member of the Board of Directors of several start-ups in the field of Life Sciences.
At the same time, he is also a Privat Docent in Pharmacology and Toxicology at the Department of Biomedical Sciences of the University of Lausanne as well as a lecturer at the School of Biology of the same university, where he teaches entrepreneurship applied to biology and industrial biotechnology.